Cart is empty Press Release Jena / Lübeck (GER) – Biotechnology company oncgnostics GmbH is announcing a collaboration with the international diagnostics group EUROIMMUN, a PerkinElmer company. As part of the cooperation, EUROIMMUN will sell the cervical cancer test from oncgnostics GmbH, Gyn-Tect,…
Der Beitrag Oncgnostics and EUROIMMUN Announce Collaboration to Distribute Cervical Cancer Test GynTect erschien zuerst auf EUROIMMUNBlog.